Vor Biopharma Inc. (NYSE:VOR) Given Consensus Recommendation of "Buy" by Analysts

Vor Biopharma Inc. (NYSE:VOR - Get Free Report) has been assigned an average recommendation of "Buy" from the seven research firms that are...
14 hours ago
from: MarketBeat

Nasdaq, New York Stock Exchange